Journal
FRONTIERS IN NEUROSCIENCE
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fnins.2018.00025
Keywords
Alzheimer's disease; A beta; APP; amyloid; tau; PHF
Categories
Funding
- Ministry of Education, Culture, Sports, Science, and Technology [JP26117005, JP26293084]
- Japan Society for the Promotion of Science [JP23228004]
- Japan Agency for Medical Research and Development (AMED) [JP14533254]
Ask authors/readers for more resources
The so-called amyloid hypothesis, that the accumulation and deposition of oligomeric or fibrillar amyloid beta (A beta) peptide is the primary cause of Alzheimer's disease (AD), has been the mainstream concept underlying AD research for over 20 years. However, all attempts to develop A beta-targeting drugs to treat AD have ended in failure. Here, we review recent findings indicating that the main factor underlying the development and progression of AD is tau, not A beta, and we describe the deficiencies of the amyloid hypothesis that have supported the emergence of this idea.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available